SEC Filings

Form S-8
ZOMEDICA PHARMACEUTICALS CORP. filed this Form S-8 on 01/24/2019
Document Outline
Entire Document (236 KB)
Subdocument 1 - S-8 - FORM S-8
Page 1 - As filed with the Securities and Exchange Commission on January 24, 2019
Page 2 - CALCULATION OF REGISTRATION FEE
Page 3 - PART I
Page 4 - Neither the Securities and Exchange Commission nor any state securities commission has approved or d
Page 5 - TABLE OF CONTENTS
Page 6 - Neither we nor the selling shareholders have authorized any other person to provide you with differe
Page 7 - OUR COMPANY
Page 8 - Implications of Being an Emerging Growth Company
Page 9 - USE OF PROCEEDS
Page 10 - N/A
Page 11 - N/A
Page 12 - MATERIAL UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS
Page 13 - N/A
Page 14 - The following summary is not a substitute for careful tax planning and advice. U.S. Holders of commo
Page 15 - N/A
Page 16 - N/A
Page 17 - General Rules Applicable to the Ownership and Disposition of Common Shares
Page 18 - Additional Considerations
Page 19 - N/A
Page 20 - CERTAIN CANADIAN INCOME TAX CONSIDERATIONS
Page 21 - Dividends on Common Shares
Page 22 - PLAN OF DISTRIBUTION
Page 23 - LEGAL MATTERS
Page 24 - WHERE YOU CAN FIND MORE INFORMATION
Page 25 - 8,040,900 Common Shares
Page 26 - PART II
Page 27 - SIGNATURES
Page 28 - EXHIBIT INDEX
Subdocument 2 - EX-5.1 - EXHIBIT 5.1
Page 1 - Exhibit 5.1
Page 2 - N/A
Subdocument 3 - EX-23.1 - EXHIBIT 23.1
Page 1 - N/A